Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study.
about
Role of insulin in the type 2 diabetes therapy: past, present and futureInsulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studiesThe links between insulin resistance, diabetes, and cancerThe metabolic and mitogenic properties of basal insulin analoguesInsulin use early in the course of type 2 diabetes mellitus: the ORIGIN trialImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyCancer biology in diabetes.Diabetes medications and cancer risk: review of the literatureInsulin glargine and cancer risk in patients with diabetes: a meta-analysis.Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulinDiabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohortUse of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Cancer specific mortality in insulin-treated type 2 diabetes patients.Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/⁺WAPCre mouse modelThe role of diabetes in acromegaly associated neoplasia.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.Associations between diabetes medication use and risk of second breast cancer events and mortalityAlternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cellsDiabetes, insulin and cancer risk.Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.The insulin receptor: a new target for cancer therapy.Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'Design of non-standard insulin analogs for the treatment of diabetes mellitusInsulin therapy and cancer in type 2 diabetes.Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.Association of diabetes and diabetes treatment with incidence of breast cancer.A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factorsSmoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studiesComparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.Diabetes and cancer relationships.Insulin and IGFs in obesity-related breast cancer.Antihyperglycaemic therapies and cancer risk.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.Diabetology and oncology meet in a network model: union is strength.
P2860
Q22241148-A31EA744-8490-437B-8769-75C0E029A5DEQ24624156-6760CCDF-95E5-432B-B590-FA7752716B1EQ26823071-1B69330D-4D08-474F-B52C-9B3D5FD511EEQ26852910-BFFB477F-2DA2-40D9-ABFB-0FB3F5A72544Q26991486-D3EF0B0A-0FB6-4CA3-AD56-10BB9F3B8FA5Q27024597-5B97EAAD-6E59-494D-AC5A-DF7005D97B0FQ28535372-AD206F4D-6AD9-45DB-A63C-7D09916D3B6BQ33608038-749347A4-DFB9-41DF-ABBF-72023ED0B13FQ33714881-3EAD22ED-0271-4BF3-8CD9-3E349874C1B1Q34320632-CD627984-74B9-4862-A8BB-2C630A34C48AQ34373861-6926044B-7E8B-489E-9545-D29FD165D2C9Q34392021-2EE83401-B2B3-4CA9-A1AE-D61949F92486Q35038355-12E3F9F6-FBB1-47DE-B3DC-ADDBC9642C5CQ35131192-3C47486F-CBBC-47CC-A1F9-B0B507CCD413Q35147769-811640F8-72F9-4D47-9867-D5BB5786F9ACQ35634032-21C5302F-CFD5-4617-AEAA-CC97098EE67DQ35817986-03B63F2D-8AC7-4CA6-954F-3ADADE5D5BFAQ35832508-1B50B3FE-9DAC-4E41-A8FD-739CE6B274ECQ35850213-69927CCC-3082-4D37-865C-82410657D227Q35863765-81C9AB10-2336-49CD-B0CB-F0425082E641Q35906970-92C5A3BD-B3DD-46A5-94B1-032D58ED2503Q35937961-8F1B20B1-FD50-4795-9EE3-6B4DEEF09FC3Q35972002-CAE97569-103B-4E03-9CA1-0EC000F33A98Q35988978-B1050A48-1C6E-4CB5-8138-904F8096F1E9Q36073447-50CAB82A-CB1D-4F1C-878C-21102367695DQ36374363-978A53D3-52BC-4CDD-AA0C-CDA7E10DF08AQ36417868-B687F404-35B4-4D10-846C-36EA59239F11Q36560372-FCBF4C04-96DD-4259-8A2E-9F279321F92CQ36568614-5587E813-7851-4D0D-B943-9663AC8F0638Q37105231-09CEC91C-FCAB-4450-B0D3-16926E4F5BEAQ37176065-7B7B5B20-749A-4DF1-9FF0-310972A84D8BQ37228939-A9753426-877F-4310-88F8-2F3CA09D6FC3Q37278227-353367EF-38CB-477A-AE79-78D75F004C42Q37331188-11F26F09-7257-41F8-B83A-5E845E023BA2Q37982674-325BF4E9-ADD5-48E1-8705-B366AF27A7FDQ38097984-FADE64A2-7611-4587-A66C-E8D78482D606Q38155073-56B23FCD-6482-4B44-9B00-64F468CBB958Q38250719-6AC83EA2-5A62-49A5-99D0-042E003F42B8Q38651175-9B3AA68A-61E2-43BB-BCE9-0718DFD2B0B7Q38728033-C60756FB-B6DB-4B3D-83EA-A65800466F07
P2860
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Risk of cancer in patients on ...... ulation-based follow-up study.
@ast
Risk of cancer in patients on ...... ulation-based follow-up study.
@en
type
label
Risk of cancer in patients on ...... ulation-based follow-up study.
@ast
Risk of cancer in patients on ...... ulation-based follow-up study.
@en
prefLabel
Risk of cancer in patients on ...... ulation-based follow-up study.
@ast
Risk of cancer in patients on ...... ulation-based follow-up study.
@en
P2093
P2860
P1433
P1476
Risk of cancer in patients on ...... ulation-based follow-up study.
@en
P2093
B H Ch Stricker
J W W Coebergh
L E Visser
M P P van Herk-Sukel
P H Geelhoed-Duijvestijn
R M C Herings
S M J M Straus
P2860
P2888
P356
10.1007/S00125-011-2312-4
P577
2011-09-29T00:00:00Z